Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 204325

Marketing Status: Discontinued
Active Ingredient: AMPHETAMINE
Proprietary Name: ADZENYS ER
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; ORAL
Strength: EQ 1.25MG BASE/ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N204325
Product Number: 001
Approval Date: Sep 15, 2017
Applicant Holder Full Name: NEOS THERAPEUTICS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English